BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 33915956)

  • 1. Exosomes from Plasma of Neuroblastoma Patients Contain Doublestranded DNA Reflecting the Mutational Status of Parental Tumor Cells.
    Degli Esposti C; Iadarola B; Maestri S; Beltrami C; Lavezzari D; Morini M; De Marco P; Erminio G; Garaventa A; Zara F; Delledonne M; Ognibene M; Pezzolo A
    Int J Mol Sci; 2021 Apr; 22(7):. PubMed ID: 33915956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma-Derived Exosome Proteins as Novel Diagnostic and Prognostic Biomarkers in Neuroblastoma Patients.
    Morini M; Raggi F; Bartolucci M; Petretto A; Ardito M; Rossi C; Segalerba D; Garaventa A; Eva A; Cangelosi D; Bosco MC
    Cells; 2023 Oct; 12(21):. PubMed ID: 37947594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteome profiling of neuroblastoma-derived exosomes reveal the expression of proteins potentially involved in tumor progression.
    Marimpietri D; Petretto A; Raffaghello L; Pezzolo A; Gagliani C; Tacchetti C; Mauri P; Melioli G; Pistoia V
    PLoS One; 2013; 8(9):e75054. PubMed ID: 24069378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of tumor ALK status in neuroblastoma patients using peripheral blood.
    Combaret V; Iacono I; Bellini A; Bréjon S; Bernard V; Marabelle A; Coze C; Pierron G; Lapouble E; Schleiermacher G; Blay JY
    Cancer Med; 2015 Apr; 4(4):540-50. PubMed ID: 25653133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Copy number status and mutation analyses of anaplastic lymphoma kinase (ALK) gene in 90 sporadic neuroblastoma tumors.
    Bagci O; Tumer S; Olgun N; Altungoz O
    Cancer Lett; 2012 Apr; 317(1):72-7. PubMed ID: 22085494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-resolution array CGH profiling identifies Na/K transporting ATPase interacting 2 (NKAIN2) as a predisposing candidate gene in neuroblastoma.
    Romania P; Castellano A; Surace C; Citti A; De Ioris MA; Sirleto P; De Mariano M; Longo L; Boldrini R; Angioni A; Locatelli F; Fruci D
    PLoS One; 2013; 8(10):e78481. PubMed ID: 24205241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteomic Analysis of Neuroblastoma-Derived Exosomes: New Insights into a Metastatic Signature.
    Colletti M; Petretto A; Galardi A; Di Paolo V; Tomao L; Lavarello C; Inglese E; Bruschi M; Lopez AA; Pascucci L; Geoerger B; Peinado H; Locatelli F; Di Giannatale A
    Proteomics; 2017 Dec; 17(23-24):. PubMed ID: 28722341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BLM germline and somatic PKMYT1 and AHCY mutations: Genetic variations beyond MYCN and prognosis in neuroblastoma.
    Novak EM; Halley NS; Gimenez TM; Rangel-Santos A; Azambuja AM; Brumatti M; Pereira PL; Vince CS; Giorgi RR; Bendit I; Cristofani LM; Odone-Filho V
    Med Hypotheses; 2016 Dec; 97():22-25. PubMed ID: 27876123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genomic Analysis Made It Possible to Identify Gene-Driver Alterations Covering the Time Window between Diagnosis of Neuroblastoma 4S and the Progression to Stage 4.
    Ognibene M; De Marco P; Parodi S; Meli M; Di Cataldo A; Zara F; Pezzolo A
    Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35742955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NK Cell-derived Exosomes From NK Cells Previously Exposed to Neuroblastoma Cells Augment the Antitumor Activity of Cytokine-activated NK Cells.
    Shoae-Hassani A; Hamidieh AA; Behfar M; Mohseni R; Mortazavi-Tabatabaei SA; Asgharzadeh S
    J Immunother; 2017 Sep; 40(7):265-276. PubMed ID: 28622272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exosomes from Irradiated Nonsmall Cell Lung Cancer Cells Reduced Sensitivity of Recipient Cells to Anaplastic Lymphoma Kinase Inhibitors.
    Wu H; Zeng C; Ye Y; Liu J; Mu Z; Xie Y; Chen B; Nong Q; Wu D
    Mol Pharm; 2018 May; 15(5):1892-1900. PubMed ID: 29595984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PHOX2B analysis in non-syndromic neuroblastoma cases shows novel mutations and genotype-phenotype associations.
    McConville C; Reid S; Baskcomb L; Douglas J; Rahman N
    Am J Med Genet A; 2006 Jun; 140(12):1297-301. PubMed ID: 16691592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exosomal hsa-piR1089 promotes proliferation and migration in neuroblastoma via targeting KEAP1.
    Wang H; Shi B; Zhang X; Shen P; He Q; Yin M; Pan Y; Ma J
    Pathol Res Pract; 2023 Jan; 241():154240. PubMed ID: 36436316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [ALK gene mutations in childhood neuroblastoma].
    Yang CL; Yue LJ; Jiang XP; Wen FQ; Zheng MM
    Zhongguo Dang Dai Er Ke Za Zhi; 2012 Oct; 14(10):763-6. PubMed ID: 23092569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Whole-genome sequencing of recurrent neuroblastoma reveals somatic mutations that affect key players in cancer progression and telomere maintenance.
    Fransson S; Martinez-Monleon A; Johansson M; Sjöberg RM; Björklund C; Ljungman G; Ek T; Kogner P; Martinsson T
    Sci Rep; 2020 Dec; 10(1):22432. PubMed ID: 33384420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of mutant KRAS and TP53 DNA in circulating exosomes from healthy individuals and patients with pancreatic cancer.
    Yang S; Che SP; Kurywchak P; Tavormina JL; Gansmo LB; Correa de Sampaio P; Tachezy M; Bockhorn M; Gebauer F; Haltom AR; Melo SA; LeBleu VS; Kalluri R
    Cancer Biol Ther; 2017 Mar; 18(3):158-165. PubMed ID: 28121262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of drug-resistant neuroblastoma cell lines by comparative genomic hybridization.
    Bedrnicek J; Vicha A; Jarosova M; Holzerova M; Cinatl J; Michaelis M; Cinatl J; Eckschlager T
    Neoplasma; 2005; 52(5):415-9. PubMed ID: 16151587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The mitochondrial genetic landscape in neuroblastoma from tumor initiation to relapse.
    Riehl LM; Schulte JH; Mulaw MA; Dahlhaus M; Fischer M; Schramm A; Eggert A; Debatin KM; Beltinger C
    Oncotarget; 2016 Feb; 7(6):6620-5. PubMed ID: 26735174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New therapeutic strategies in neuroblastoma: combined targeting of a novel tyrosine kinase inhibitor and liposomal siRNAs against ALK.
    Di Paolo D; Yang D; Pastorino F; Emionite L; Cilli M; Daga A; Destafanis E; Di Fiore A; Piaggio F; Brignole C; Xu X; Liang C; Gibbons J; Ponzoni M; Perri P
    Oncotarget; 2015 Oct; 6(30):28774-89. PubMed ID: 26299615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Abnormality of anaplastic lymphoma kinase gene and its expression in pediatric neuroblastoma].
    Chen S; Zhou C; Ma X; Gong L
    Zhonghua Bing Li Xue Za Zhi; 2014 Aug; 43(8):541-5. PubMed ID: 25346125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.